Drug Development Institute
Biotechnology, 460 W 10th Ave Fl 5, Columbus, Ohio, 43210, United States, 11-50 Employees
Phone Number: 61********
Who is DRUG DEVELOPMENT INSTITUTE
The Drug Development Institute (DDI) is a biotech-like institute embedded in The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Re...
Read More
-
Headquarters: 460 W 10th Ave Fl 5, Columbus, Ohio, 43210, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $100 Million to $250 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8733
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from DRUG DEVELOPMENT INSTITUTE
Drug Development Institute Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Drug Development Institute
Answer: Drug Development Institute's headquarters are located at 460 W 10th Ave Fl 5, Columbus, Ohio, 43210, United States
Answer: Drug Development Institute's phone number is 61********
Answer: Drug Development Institute's official website is https://cancer.osu.edu
Answer: Drug Development Institute's revenue is $100 Million to $250 Million
Answer: Drug Development Institute's SIC: 8733
Answer: Drug Development Institute's NAICS: 541714
Answer: Drug Development Institute has 11-50 employees
Answer: Drug Development Institute is in Biotechnology
Answer: Drug Development Institute contact info: Phone number: 61******** Website: https://cancer.osu.edu
Answer: The Drug Development Institute (DDI) is a biotech-like institute embedded in The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James). By bringing an industry-focused perspective to all investment and management decisions, the DDI ensures that programs have a high likelihood of progressing to clinical stage development. Our goal is to rapidly translate Ohio States most innovative research into tomorrows most promising treatments for patients with cancer. The DDI employs a combination of targeted investments, strategic management and cutting-edge drug development resources to drive projects from discovery through early drug development, thus creating high-value new drug candidates. The DDI Pipeline: Research: The DDI leverages world-class research and drug development resources at The Ohio State University to advance projects from early drug discovery through preclinical and clinical development. Advisory Board: The DDI Advisory Board consists of internationally recognized experts with proven track records in pharmaceutical drug discovery, development and commercialization. Partnerships with Industry and Venture Capitalist Firms: DDI partners with pharmaceutical, biotech and venture capital companies to bridge the gap between drug discovery and early clinical development, accelerating development timelines and delivering innovative treatments to patients sooner.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month